ClinicalTrials.Veeva

Menu

Treatment of Severe Male Infertility - Predictive Factors (Imaging) (TESE-MRI)

T

Turku University Hospital (TYKS)

Status

Completed

Conditions

Male Infertility

Treatments

Diagnostic Test: MRI

Study type

Observational

Funder types

Other

Identifiers

NCT02931721
TESE-MRI

Details and patient eligibility

About

Testes of men with non-obstructive azoospermia (NOA) are imaged using MRI to find potential differences depending on the outcome, ie. sperm recovery in consequent microdissection testicular sperm extraction (MD-TESE).

Full description

Sperm recovery rate in non-obstructive azoospermia (NOA) men is 43% in Turku University Hospital, depending on the diagnosis leading to NOA. To date, there are no known parameters known to differentiate between successful and unsuccessful sperm recovery.

MRI is performed on men prior to the operation, and the objective is to compare the functional parameters assessed by magnetic resonance imaging between the group of men with positive and the men with negative sperm recovery in testicular microdissection sperm extraction (MD-TESE).

Enrollment

30 patients

Sex

Male

Ages

18 to 50 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • non obstructive azospermia

Exclusion criteria

  • malignancy
  • contraindication for fertility treatment

Trial design

30 participants in 3 patient groups

MRI Positive
Description:
Men with sperm found in MD-TESE
Treatment:
Diagnostic Test: MRI
MRI Negative
Description:
Men with no sperm found in MD-TESE
Treatment:
Diagnostic Test: MRI
Control group
Description:
No intervention, fertile
Treatment:
Diagnostic Test: MRI

Trial contacts and locations

2

Loading...

Central trial contact

Rauni Klami, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems